A Chicago federal judge said Prime Therapeutics' confidentiality and disclosure concerns could not prevent discovery from moving forward in a lawsuit over Walgreen Co.'s Prescription Savings Club.

According to the plaintiff, Datavault AI, all it took was a bad review and a barrage of negative social media posts from the financial research and due diligence firm, Wolfpack Research, to put the company's reputation in a tailspin.

The president has had mixed success in challenging his legal travails at the Supreme Court.

Despite the appeals cases being on hold for over a month, the federal government has tapped a new attorney to argue on its behalf, with Deputy Associate Attorney General Abhishek Kambli entering a notice of appearance.

"Inconsistent messaging is one of the biggest pitfalls,” Judge Paula Patrick of the Philadelphia Court of Common Pleas said during her keynote at General Counsel Conference East on Tuesday. "Internal documents, witnesses and experts might all be saying different things than what you're trying to portray."

"This was a very significant win for Kalshi and the predictions market space more generally," said Renato Mariotti, a partner at Paul Hastings who closely follows prediction markets and is not involved in the case.

"The logo fiasco may be a single incident, but in the public eye it has come to define the company," Institutional Shareholder Services said in a note to clients.